Interested in specific information?

Filter what you see here

Quick poll

EHA 2019 | Should we use PTCy or ATG as GvHD prophylaxis in…

EHA 2019 | Should we use PTCy or ATG as GvHD prophylaxis in haploidentical stem cell transplantation?

Closes Jun 20, 2019

aGvHD

Quick poll

EHA 2019 | What are the current treatment recommendations for acute…

Closes Jun 19, 2019

cGvHD

Quick poll

EHA 2019 | Clinical practice in chronic GvHD

Closes Jun 18, 2019

aGvHD,   cGvHD

Quick poll

EHA 2019 | How can we better utilize FMT in patients undergoing stem…

EHA 2019 | How can we better utilize FMT in patients undergoing stem cell transplantation?

Closes Jun 17, 2019

aGvHD,   cGvHD

Quick poll

ASCO 2019 | Results of a phase II study: Post-transplant cyclophosphamide…

Closes Jun 13, 2019

aGvHD

Quick poll

EBMT GvHD Summit 2019 | Acute GvHD diagnosis

Closes Jun 11, 2019

aGvHD

Quick poll

FDA agrees to a rolling review towards the BLA for remestemcel-l in the…

FDA agrees to a rolling review towards the BLA for remestemcel-l in the treatment of aGvHD

Closes Jun 10, 2019

aGvHD

Quick poll

EBMT GvHD Summit 2019 | Treatment of acute GvHD based on the…

Closes May 29, 2019

GvHD Prophylaxis

Quick poll

EBMT GvHD Summit 2019 | Prophylaxis of GvHD – EBMT–ELN working…

Closes May 29, 2019

aGvHD

Quick poll

Ruxolitinib approved by the FDA for steroid refractory acute GvHD

Ruxolitinib approved by the FDA for steroid refractory acute GvHD

Closes May 28, 2019

aGvHD,   cGvHD

Quick poll

Post-transplant cyclophosphamide use in matched HLA donors

Closes May 24, 2019

GvHD Prophylaxis,   aGvHD,  cGvHD

Quick poll

Highlights from the 1st EBMT GvHD Summit 2019

Closes May 18, 2019

cGvHD,   aGvHD

Quick poll

Pathogenicity and alloresponse of T cells confined by thioredoxin-1

Pathogenicity and alloresponse of T cells confined by thioredoxin-1

Closes May 17, 2019

GvHD Prophylaxis,   aGvHD,  cGvHD

Quick poll

MyD88 signaling in donor T cells accelerates graft-versus-host disease

Closes May 14, 2019

cGvHD

Quick poll

Chronic GvHD: management and future perspectives

Closes May 10, 2019
A global online platform providing latest treatment options and medical information in graft versus host disease

Latest Medical Information

Expert Opinions

Congress coverage

Upcoming congress

24th Meeting of the European Hematology Association (EHA)

June 13 - June 16, 2019 | Amsterdam, NL

The GvHD Hub will be attending the 24th Meeting of the European Hematology Association (EHA) in Amsterdam, NL. We will be presenting live coverage via our social media channels, interviewing world-leading experts and providing summaries of key sessions. Stay tuned to follow our first-hand coverage.

Use the following hashtags on Twitter to join the conversation: #GvHD #gvhdsm

Event Website

Map Data
Map data ©2019 Google
Map DataMap data ©2019 Google
Map data ©2019 Google

Connect with us

Our sister hubs

Visit our other community physician education hubs in haematology and oncology